Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving - 2The Electric Bicycle Americans Can Confide in 2024
- 3Figure out How to Alter Your Volvo XC40 for Further developed Solace
- 46 Exercises to Anticipate in 2024
- 5Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- How much would you pay to meet a Real Housewife? At BravoCon, the limit does not exist.
- Manual for Instructive Application for Youngsters
- What to watch for in weight loss drugs in 2026
- Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
- Best Food Truck Cooking: Decision in favor of Your Number one!
- Congo declares its latest Ebola outbreak over, after 43 deaths
- PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
